The criteria have been modified over time and the most recent version is shown below. In the past the criteria depended mainly on laboratory values, such as a decrease in hemoglobin or hematocrit values. These criteria were developed during early TIMI trials to define minor and major hemorrhagic episodes in patients of ST segment elevation MI (STEMI) treated with a fibrinolytic drug and have been there for 30 years. The Thrombolysis in Myocardial Infarction (TIMI) bleeding criteria is one of the most frequently used classifications in the cardiovascular trials. Risk calculators and risk factors for TIMI bleeding criteriaĮditor-In-Chief: C. Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric SurgeryĬongenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding DisordersĪmerican Roentgen Ray Society Images of TIMI bleeding criteriaĪll Images X-rays Echo & Ultrasound CT Images MRIĭirections to Hospitals Treating Bleeding Reversal of Anticoagulation and Antiplatelet in Active Bleedĭiscontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
0 kommentar(er)
